Automated Sperm Selection
InfertilityIntracytoplasmic sperm injection (ICSI) is one of the standard clinical treatments for infertility. ICSI involves the injection of a single sperm into an oocyte with a sharp micropipette. Injecting a sperm with DNA fragmentation (i.e., physical breakage of the DNA double strands) into the oocyte deterministically lowers the IVF fertilization rate \[1\]\[2\] and increases the miscarriage rate \[3\]\[4\]. Since the invention of ICSI in 1992, single sperm selection in ICSI has been made manually by embryologists, who select sperm by qualitatively choosing sperm with "good" motility and/or morphology based on their empirical experience. This involves significant subjectivity and inconsistency. We have developed a robotic system to select sperm with low sperm DNA fragmentation. Automated sperm selection also eliminates the subjectivity and inconsistency in manual sperm selection. The system consists of a camera to acquire images of sperm and a software to analyze the images. Embryologists select sperm by observing the same sperm characteristics as in the software criteria (e.g., speed etc.), but the software provides a more accurate and quantitative measure of sperm characteristics, thus ensuring the selected sperm have low DNA fragmentation.
null
Conditions de participation
-
Sexe:
ALL -
Âges admissibles:
19 to 43
Critères de participation
Inclusion Criteria:
* Patients undergoing ICSI
* Female partner between 19-43 years of age using own or donor oocytes
Exclusion Criteria:
* Patients who do not provide informed consent
* Patients with less than 6 mature eggs collected
* Patients undergoing IVF without ICSI
* Morphology \<4% normal forms
* 100% immotile sperm
* Cases where surgically-retrieved sperm is used for ICSI
Lieu de l'étude
CReATe Fertility Centre
CReATe Fertility CentreToronto, Ontario
Canada
Contactez l'équipe d'étude
- Étude parrainée par
- Create Fertility Center
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT05240469